{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:40:51Z","timestamp":1790023251699,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Recurrent vulvovaginal candidiasis (RVVC) is experienced by up to 10% of pre-menopausal women globally, yet there is limited research exploring the perspective of women living with this challenging condition.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Semi-structured interviews with Australian women experiencing RVVC were conducted between April\u2013July 2021. Interviews were transcribed verbatim, and qualitative interpretative phenomenological analysis (IPA) was conducted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Ten RVVC patients were interviewed. IPA revealed an uncertain journey living with RVVC for all participants ranging from initial symptoms and difficulties in obtaining a diagnosis, the trial and error of symptom management, to the overall debilitating impact of living with a personal and intimate health condition. Four key themes were identified: Theme 1 outlined challenges and delays in diagnosis and clinically appropriate management. Theme 2 found that health care professional (HCP) knowledge limitations impacted RVVC management. Theme 3 illustrated the consequences of a lack of HCP support leading to self-referral and self-education. Theme 4 details the significant emotional and psycho-social repercussions of RVVC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This debilitating, life-long disease has a prolonged effect on women both physically and psychologically. Living with RVVC seems an uncertain journey that, to a large degree, women feel they must navigate alone. While resilience and self-empowerment were noted, better support through evidence-based treatment options, educated and evidence-informed HCPs and a sympathetic social support network is needed to decrease the disease burden. Future clinical management guidelines and patient support need to consider the findings of this study.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-022-01973-x","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T15:02:44Z","timestamp":1663599764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Lived experience of medical management in recurrent vulvovaginal candidiasis: a qualitative study of an uncertain journey"],"prefix":"10.1186","volume":"22","author":[{"given":"Moira","family":"Bradfield Strydom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh L.","family":"Walpola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohil","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelin","family":"Tiralongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,19]]},"reference":[{"issue":"11","key":"1973_CR1","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/S1473-3099(18)30103-8","volume":"18","author":"DW Denning","year":"2018","unstructured":"Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18(11):e339\u201347.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1973_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ajog.2015.06.067","volume":"214","author":"JD Sobel","year":"2016","unstructured":"Sobel JD. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2016;214(1):15\u201321.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1973_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/LGT.0b013e318287aced","volume":"18","author":"E Hong","year":"2014","unstructured":"Hong E, Dixit S, Fidel PL, Bradford J, Fischer G. Vulvovaginal candidiasis as a chronic disease: diagnostic criteria and definition. J Low Genit Tract Dis. 2014;18(1):31\u20138.","journal-title":"J Low Genit Tract Dis"},{"issue":"1","key":"1973_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/LGT.0000000000000496","volume":"24","author":"LM Collins","year":"2020","unstructured":"Collins LM, Moore R, Sobel JD. Prognosis and Long-Term Outcome of Women With Idiopathic Recurrent Vulvovaginal Candidiasis Caused by Candida albicans. J Low Genit Tract Dis. 2020;24(1):48\u201352.","journal-title":"J Low Genit Tract Dis"},{"issue":"1","key":"1973_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1472-6874-14-43","volume":"14","author":"SD Rathod","year":"2014","unstructured":"Rathod SD, Buffler PA. Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented. BMC Womens Health. 2014;14(1):43.","journal-title":"BMC Womens Health"},{"key":"1973_CR6","doi-asserted-by":"crossref","unstructured":"Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019;220(4):354.e1\u2013.e12.","DOI":"10.1016\/j.ajog.2018.12.039"},{"issue":"1","key":"1973_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4236\/asm.2017.71001","volume":"7","author":"A Adolfsson","year":"2017","unstructured":"Adolfsson A, Hagander A, Mahjoubipour F, Larsson P-G. How vaginal infections impact women\u2019s everyday life: women\u2019s lived experiences of bacterial Vaginosis and recurrent vulvovaginal candidiasis. Adv Sex Med. 2017;7(1):1\u201319.","journal-title":"Adv Sex Med"},{"issue":"2","key":"1973_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/ajo.12592","volume":"57","author":"A Matheson","year":"2017","unstructured":"Matheson A, Mazza D. Recurrent vulvovaginal candidiasis: a review of guideline recommendations. Aust NZ J Obstet Gynaecol. 2017;57(2):139\u201345.","journal-title":"Aust NZ J Obstet Gynaecol"},{"key":"1973_CR9","doi-asserted-by":"crossref","unstructured":"Cooke G, Watson C, Deckx L, Pirotta M, Smith J, van Driel ML. Treatment for recurrent vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev. 2022;1.","DOI":"10.1002\/14651858.CD009151.pub2"},{"key":"1973_CR10","doi-asserted-by":"crossref","unstructured":"Bradfield Strydom M, Walpola RL, Khan S, Ware RS, Tiralongo E. Evidence\u2010based update on Australasian pharmaceutical prescribing approaches for recurrent vulvovaginal candidiasis. Aust NZ J Obstet Gynaecol. 2021;61(4):496-9.","DOI":"10.1111\/ajo.13376"},{"issue":"4","key":"1973_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ctim.2012.01.004","volume":"20","author":"C Watson","year":"2012","unstructured":"Watson C, Pirotta M, Myers P. Use of complementary and alternative medicine in recurrent vulvovaginal candidiasis\u2014results of a practitioner survey. Complement Ther Med. 2012;20(4):218\u201321.","journal-title":"Complement Ther Med"},{"issue":"4","key":"1973_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/713683045","volume":"18","author":"A Chapple","year":"2000","unstructured":"Chapple A, Hassell K, Nicolson M, Cantrill J. \u201cYou don\u2019t really feel you can function normally\u201d: women\u2019s perceptions and personal management of vaginal thrush. J Reprod Infant Psychol. 2000;18(4):309\u201319.","journal-title":"J Reprod Infant Psychol"},{"issue":"4","key":"1973_CR13","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1111\/ajd.12487","volume":"58","author":"Y Nguyen","year":"2017","unstructured":"Nguyen Y, Lee A, Fischer G. Quality of life in patients with chronic vulvovaginal candidiasis: a before and after study on the impact of oral fluconazole therapy. Australas J Dermatol. 2017;58(4):e176\u201381.","journal-title":"Australas J Dermatol"},{"issue":"3","key":"1973_CR14","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00404-019-05228-3","volume":"300","author":"EI Fukazawa","year":"2019","unstructured":"Fukazawa EI, Witkin SS, Robial R, Vinagre JG, Baracat EC, Linhares IM. Influence of recurrent vulvovaginal candidiasis on quality of life issues. Arch Gynecol Obstet. 2019;300(3):647\u201350.","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"1973_CR15","first-page":"1","volume":"3","author":"O Richard","year":"2017","unstructured":"Richard O, Asare B, Paul OB. Perception and practice of women on vaginal discharge in relation to reproductive health and the way forward: a study at Mampong Akuapem-Eastern region of Ghana. Int J Innov Res Multidiscip Field. 2017;3(4):1\u20136.","journal-title":"Int J Innov Res Multidiscip Field"},{"issue":"1","key":"1973_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12955-016-0470-2","volume":"14","author":"Y-X Zhu","year":"2016","unstructured":"Zhu Y-X, Li T, Fan S-R, Liu X-P, Liang Y-H, Liu P. Health-related quality of life as measured with the Short-Form 36 (SF-36) questionnaire in patients with recurrent vulvovaginal candidiasis. Health Qual Life Outcomes. 2016;14(1):65.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"1973_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/1477-7525-11-169","volume":"11","author":"S Aball\u00e9a","year":"2013","unstructured":"Aball\u00e9a S, Guelfucci F, Wagner J, Khemiri A, Dietz J-P, Sobel J, et al. Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA. Health Qual Life Outcomes. 2013;11(1):169.","journal-title":"Health Qual Life Outcomes"},{"key":"1973_CR18","doi-asserted-by":"crossref","unstructured":"Smith JA, Shinebourne P. Interpretative phenomenological analysis. APA handbook of research methods in psychology, vol 2: Research designs: quantitative, qualitative, neuropsychological, and biological. APA handbooks in psychology\u00ae. Washington, DC, US: American Psychological Association; 2012. p. 73\u201382.","DOI":"10.1037\/13620-005"},{"key":"1973_CR19","unstructured":"Lime Survey. In: Team CSL, editor. Version 2.59 +170116 ed. Hamburg: Lime Survey Team."},{"issue":"1","key":"1973_CR20","doi-asserted-by":"publisher","first-page":"160940691773384","DOI":"10.1177\/1609406917733847","volume":"16","author":"LS Nowell","year":"2017","unstructured":"Nowell LS, Norris JM, White DE, Moules NJ. Thematic analysis: striving to meet the trustworthiness criteria. Int J Qual Methods. 2017;16(1):1609406917733847.","journal-title":"Int J Qual Methods"},{"issue":"1","key":"1973_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12905-019-0748-8","volume":"19","author":"J Yano","year":"2019","unstructured":"Yano J, Sobel JD, Nyirjesy P, Sobel R, Williams VL, Yu Q, et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Womens Health. 2019;19(1):48.","journal-title":"BMC Womens Health"},{"issue":"1","key":"1973_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-021-01223-6","volume":"21","author":"GL Bentham","year":"2021","unstructured":"Bentham GL, Manley K, Halawa S, Biddle L. Conversations between women with vulval lichen sclerosus: a thematic analysis of online forums. BMC Womens Health. 2021;21(1):1\u20139.","journal-title":"BMC Womens Health"},{"issue":"5","key":"1973_CR23","doi-asserted-by":"publisher","first-page":"260","DOI":"10.15406\/ogij.2017.07.00260","volume":"7","author":"VM Lema","year":"2017","unstructured":"Lema VM. Recurrent vulvo-vaginal candidiasis: diagnostic and management challenges in a developing country context. Obstet Gynecol Int J. 2017;7(5):260.","journal-title":"Obstet Gynecol Int J"},{"key":"1973_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/978-981-13-1577-0_14","volume-title":"Infectious diseases and your health","author":"J Singh","year":"2018","unstructured":"Singh J, Kalia N, Kaur M. Recurrent vulvovaginal infections: etiology, diagnosis, treatment and management. In: Singh PP, editor. Infectious diseases and your health. Singapore: Springer; 2018. p. 257\u201389."},{"issue":"3","key":"1973_CR25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1701-2163(15)30316-9","volume":"37","author":"J Van Schalkwyk","year":"2015","unstructured":"Van Schalkwyk J, Yudin MH, Allen V, Bouchard C, Boucher M, Boucoiran I, et al. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis. J Obstet Gynaecol Can. 2015;37(3):266\u201374.","journal-title":"J Obstet Gynaecol Can"},{"issue":"13","key":"1973_CR26","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/1471-0528.15913","volume":"126","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhang X, Zhou Yy, Jiang Cm, Jiang Hy. The safety of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis. BJOG Int J Obstet Gynaecol. 2019;126(13):1546\u201352.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"1973_CR27","doi-asserted-by":"crossref","unstructured":"Story K, Sobel R. Fluconazole prophylaxis in prevention of symptomatic candida vaginitis. Curr Infect Dis Rep. 2020;22(1):1\u20134.","DOI":"10.1007\/s11908-020-0712-7"},{"issue":"3\u20131","key":"1973_CR28","first-page":"103","volume":"7","author":"A Mitsi","year":"2018","unstructured":"Mitsi A, Kourakos M, Poulimenakou G, Latsou D, Sarris M. Therapeutic relationship and quality of life in chronic diseases. Am J Nurs Sci. 2018;7(3\u20131):103\u20138.","journal-title":"Am J Nurs Sci"},{"issue":"1","key":"1973_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12875-020-01294-8","volume":"21","author":"M Kang","year":"2020","unstructured":"Kang M, Robards F, Luscombe G, Sanci L, Usherwood T. The relationship between having a regular general practitioner (GP) and the experience of healthcare barriers: a cross-sectional study among young people in NSW, Australia, with oversampling from marginalised groups. BMC Fam Pract. 2020;21(1):1\u20139.","journal-title":"BMC Fam Pract"},{"issue":"1","key":"1973_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-38279-8","volume":"9","author":"H Foley","year":"2019","unstructured":"Foley H, Steel A, Cramer H, Wardle J, Adams J. Disclosure of complementary medicine use to medical providers: a systematic review and meta-analysis. Sci Rep. 2019;9(1):1\u201317.","journal-title":"Sci Rep"},{"issue":"4","key":"1973_CR31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1159\/000314022","volume":"70","author":"GG Donders","year":"2010","unstructured":"Donders GG, Bellen G, Mendling W. Management of recurrent vulvo-vaginal candidosis as a chronic illness. Gynecol Obstet Invest. 2010;70(4):306\u201321.","journal-title":"Gynecol Obstet Invest"},{"issue":"10","key":"1973_CR32","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1258\/ijsa.2012.011382","volume":"23","author":"C Ekpenyong","year":"2012","unstructured":"Ekpenyong C, Inyang-Etoh E, Ettebong E, Akpan U, Ibu J, Daniel N. Recurrent vulvovaginal candidosis among young women in south eastern Nigeria: the role of lifestyle and health-care practices. Int J STD AIDS. 2012;23(10):704\u20139.","journal-title":"Int J STD AIDS"},{"key":"1973_CR33","doi-asserted-by":"crossref","unstructured":"Lines A, Vardi-Flynn I, Searle C. Recurrent vulvovaginal candidiasis. BMJ. 2020;369(1):1\u20134.","DOI":"10.1136\/bmj.m1995"},{"issue":"5","key":"1973_CR34","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1136\/sti.74.5.334","volume":"74","author":"G Irving","year":"1998","unstructured":"Irving G, Miller D, Robinson A, Reynolds S, Copas AJ. Psychological factors associated with recurrent vaginal candidiasis: a preliminary study. Sex Transm Infect. 1998;74(5):334.","journal-title":"Sex Transm Infect"},{"key":"1973_CR35","unstructured":"Organization WH. WHO global strategy on people-centred and integrated health services: interim report. World Health Organization; 2015."},{"issue":"3","key":"1973_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1439-0507.2006.01235.x","volume":"49","author":"H Meyer","year":"2006","unstructured":"Meyer H, Goettlicher S, Mendling W. Stress as a cause of chronic recurrent vulvovaginal candidosis and the effectiveness of the conventional antimycotic therapy. Mycoses. 2006;49(3):202\u20139.","journal-title":"Mycoses"},{"issue":"2","key":"1973_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4274\/jtgga.galenos.2019.2019.0077","volume":"21","author":"Z Moshfeghy","year":"2020","unstructured":"Moshfeghy Z, Tahari S, Janghorban R, Najib FS, Mani A, Sayadi M. Association of sexual function and psychological symptoms including depression, anxiety and stress in women with recurrent vulvovaginal candidiasis. J Turk German Gynecol Assoc. 2020;21(2):90.","journal-title":"J Turk German Gynecol Assoc"},{"issue":"9","key":"1973_CR38","doi-asserted-by":"publisher","first-page":"e74378","DOI":"10.1371\/journal.pone.0074378","volume":"8","author":"JE Bilardi","year":"2013","unstructured":"Bilardi JE, Walker S, Temple-Smith M, McNair R, Mooney-Somers J, Bellhouse C, et al. The burden of bacterial vaginosis: women\u2019s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS ONE. 2013;8(9):e74378.","journal-title":"PLoS ONE"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-01973-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-022-01973-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-01973-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T03:36:10Z","timestamp":1663644970000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-022-01973-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1973"],"URL":"https:\/\/doi.org\/10.1186\/s12905-022-01973-x","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,19]]},"assertion":[{"value":"19 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the Declaration of Helsinki (2000) for human studies. Ethics approval was obtained for the study from Griffith University Human Research Ethics Committee (Ref No.:2021\/144). All participants provided informed consent to participate by completing the pre-interview survey and verbally in the interviews.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to publish was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"384"}}